Rimonabant should not be prescribed in pregnancy because no sufficient data on the teratogenic/ embryotoxic risk are available. A preventive termination of pregnancy is not indicated. Women in childbearing age should take only low-risk drugs. Otherwise dedicated information, in doubt pregnancy test, and strict contraception is required.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[prescription rimonabant
4
rimonabant early
4
early stage
4
stage pregnancy?]
4
pregnancy?] rimonabant
4
rimonabant prescribed
4
prescribed pregnancy
4
pregnancy sufficient
4
sufficient data
4
data teratogenic/
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!